Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
100M
-
Shares change
-
+439K
-
Total reported value, excl. options
-
$535M
-
Value change
-
+$2.64M
-
Put/Call ratio
-
0.96
-
Number of buys
-
60
-
Number of sells
-
-68
-
Price
-
$5.34
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2021
174 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q3 2021.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100M shares
of 316M outstanding shares and own 31.75% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), TPG Group Holdings (SBS) Advisors, Inc. (16.2M shares), VANGUARD GROUP INC (11.3M shares), BlackRock Inc. (6.95M shares), Eversept Partners, LP (6.85M shares), Point72 Asset Management, L.P. (3.75M shares), Neuberger Berman Group LLC (3.31M shares), STATE STREET CORP (2.53M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1.88M shares), and Nuveen Asset Management, LLC (1.7M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.